The protein content of the body increases during infancy and up to the age of 4 years. The phenylalanine required for protein synthesis in early childhood includes, therefore, the phenylalanine required for the increment in weight as well as for the increase with time in the body's protein concentration. This increase in protein, and consequently in phenylalanine, is called chemical maturation. Little is known about the speed of this process, but it is assumed that it takes place mostly during the first year of life and is fully accomplished at about 4 years of age. According to Fomon (1976) , the increase in protein content represents both more fat-free body mass and less fat, as well as a greater percentage of protein in the fat-free body mass. In the newborn the protein content is 11.4% of the whole body and 12.8% of the fat-free body mass. According to Fomon's (1976) calculations, the protein content of the whole body is increased to 16.4% and of the fat-free body mass to 20.0% at the age of 36 months, and reaches the adult value of 20.5% of the fat-free body mass at the age of 4 years. Fomon (1961) gave infants undiluted cow's milk and found that the growth of the infants was within normal limits but that nitrogen retention was much higher than in infants given human milk. His conclusion was that this result indicated a change in body composition. His only concern was that values from the study gave a body N content which was too high. By carcass analyses of piglets it has been shown that a high level of dietary N gives a higher body N content than a low level of dietary N (Filer & Churella, 1963) . This higher body N content is represented by a more rapid weight gain, a lower percentage of body-weight as fat and a higher percentage of protein in the fat-free body mass.
We have studied the problem of chemical maturation in a long-term study of children with phenylketonuria (PKU). These children were on a very strict dietary regimen, which
ELISABETH K I N D T A N D OTHERS
made it possible to calculate exactly what the child ate over many years. Kindt et al. (1983) have previously reported the results of a comparison of two groups of children with classical PKU (Tourian & Sidbury, 1974) receiving diets differing only in the amount of protein. The group with the higher intake (RDA group) received protein at a level based on that recommended by the (US) Food and Nutrition Board (1974,1980) . The group with the lower intake (FA0 group) received protein at the level recommended by the Joint FAO/WHO ad hoc Expert Committee (1973). The result of the study suggested that the Joint FAO/WHO (1973) recommendations were borderline and possibly too low. Thus we investigated other criteria that would help clarify our findings. As a well-regulated plasma phenylalanine concentration is the objective in the treatment of children with PKU, we measured the phenylalanine intake of the two groups necessary to maintain the plasma level within the required range. The results suggested that the RDA group required more phenylalanine than the F A 0 group, and that possibly more N was retained in the RDA group than in the F A 0 group.
MATERIALS A N D METHODS

Subjects
All children with PKU born in Norway from January 1975 to February 1979 were included in the study. The RDA group consisted of eight children born from January 1975 to August 1976. The F A 0 group consisted of eight children born from August 1977 to February 1979. The children started the diet between 15 and 18 d of age, mean 16 d (see Table 1 , p. 438). One child in the RDA group received only human milk during the first 6 months of life and values from this period have been omitted. Blood samples were taken regularly for routine haematological and chemical analyses including total proteins, albumin, al-, a2-, /3-and y-globulins, transferrin, pre-albumin, retinol-binding protein and quantitative determination of immunglobulins. Length and weight were measured regularly and recorded on two growth charts (Sundal, 1957; Karlberg et al. 1976) . At the last visit an X-ray of the wrist was taken. A detailed description of procedures has been given in an earlier publication (Kindt et al. 1983) .
The biochemical control of the disease was determined by frequent analyses of plasma phenylalanine. During the initial period, determinations were made three times weekly until the plasma phenylalanine concentration fell within the target range of between 180 and 667ymol/l, usually within 2 weeks. Later determinations were made weekly during the first year of life, every 2 weeks during the second year of life, and later every 1 or 2 months. The weight of all children was calculated as the mean weight for each month, from the start of the dietary treatment and throughout the study.
Two subgroups with infants of similar weights at the start of the dietary treatment were established. The RDA subgroup consisted of five infants with weights between 3400 and 3820 g (mean 3620 g). The F A 0 subgroup consisted of four infants with weights between 3500 and 3860 g (mean 3640 g; see Table 1 , p. 438). The weight gains during the first 76 d on the diet were calculated for the two groups of infants.
Diet
The diet was based on Albumaid XP (Scientific Hospitals Supplies Ltd, Liverpool). The amino acids in this formula were derived from the acid-hydrolysis of ox serum from which phenylalanine had been removed. The protein content of Albumaid XP was calculated assuming that 1 g protein yields 1.2 g amino acids during hydrolysis (Milupa PKU 1 and PKU 2,1980) . Intact protein, and hence phenylalanine, was supplied from cow's milk during the first 3-5 months of life, except for some of the infants who received human milk for a few days (Lernnerdal et al. 1976) . Throughout the study the amount of milk supplement was individually regulated to maintain the plasma level of phenylalanine within the target range.
When necessary an increase or decrease of only 5-10 ml milk, representing 9 or 18 mg phenylalanine, was sufficient to alter the plasma level of phenylalanine. Small amounts of protein from vegetables and fruit were added to the diet of both groups from 3 to 5 months of age, and the protein and phenylalanine intakes were calculated using standard sources (FAO, 1970; Statens Ernaeringsrid, 1977) .
The RDA group received protein from the protein hydrolysate, milk, vegetables and fruit at the level of intake recommended by the (US) Food and Nutrition Board (1974, 1980) . The F A 0 group received a level of protein intake recommended by the Joint FAO/WHO ad hoc Expert Committee (1973) as safe levels of intake of egg or milk protein, assuming that the protein from hydrolysate, milk, vegetables and fruit at the concentrations used in the present study was equivalent to egg or milk protein.
The amount of phenylalanine (mg/kg body-weight per d) and the total amount of protein (g/kg body-weight per d) was calculated for each child as the mean intake for each month divided by the mean weight for each month. For infants with similar initial weights the total intake of protein from hydrolysate and from milk was calculated as g/76 d.
RESULTS
All children grew and developed showing normal skeletal maturation. Their electroencephalograms were normal. Haematological and chemical analyses were within the normal ranges and no difference was found between the two groups. However, a fall in linear growth velocity occurred in one child from the F A 0 group during infancy, in two from the F A 0 group from the age of 12 months and throughout the study and in one from the F A 0 group during the greater part of the second year of life. All children in the RDA group maintained a normal growth velocity. X-ray of the hand showed possible osteoporosis in five children from the F A 0 group, three of whom had a decrease in linear growth velocity, whereas no signs of osteoporosis were present in the RDA group.
Plasma phenylalanine
During the first 76 d of dietary treatment, the number of analyses (median and range) were 15 (1 3-22) and 15 (1 3-29) for the RDA and F A 0 subgroups respectively. One infant, no. 5 in the RDA subgroup, had rather high plasma phenylalanine values throughout the first 76 d of dietary treatment, the median value being 1454pmol/l. The median values for the other four infants in the RDA subgroup were from 376 to 836 ,umol/l, and in the F A 0 subgroup from 381 to 776 pmol/l. From 5 to 15 months of age the number of analyses (median and range) were 23 (18-39) and 20 (17-42) for the RDA and F A 0 groups respectively. The ranges of median values during this period were from 352 to 690 and from 412 to 703pmol/l for the RDA and F A 0 groups respectively. For both groups, the percentage of values below 121 pmol/l was 2 and the percentage above 967 prnolll was 6.
Weight
The weights of the children at the start of the dietary treatment are shown in Table 1 . At 5 and 15 months of age the weights were similar in both groups, the values (kg; mean and range) for the RDA group were 7.12 (6-18-8.32) and 10.7 (94-12.4) for 5 and 15 months respectively, and for the F A 0 group 7-28 (6.18-9.0) and 10.7 (9.2-12-0) respectively. The children in the RDA and F A 0 subgroups with similar birth weights had similar weight gains during the first 76 d on the diet. Table 2 shows the total protein intake (g/kg per d ; median and range) for both groups.
Protein and phenylalanine intakes
From the age of 4 months the RDA children received more protein than the F A 0 children.
There was a broader range of protein intake in the RDA group than in the F A 0 group. Table 2 also shows the phenylalanine intake (mg/kg per d ; median and range) and again there was a broader range ofphenylalanine intake in the RDA group than in the F A 0 group. Except for the first 15 d on the diet the RDA group required more phenylalanine than the F A 0 group to maintain the plasma phenylalanine level at the required concentration. This difference was statistically significant from 5 to 15 months of age using a one-sided Wilcoxon range test. The protein intake (g/76 d) for all infants in the RDA subgroup was greater than that for the F A 0 subgroup, both from hydrolysate alone and from hydrolysate and milk (see Table 3 ). The phenylalanine intake (g/76 d) was also greater for the RDA subgroup than for the F A 0 subgroup, although there was some overlap between the two subgroups. Fig. 1 shows the correlation between weight gain and phenylalanine intake, within each subgroup, during the first 76 d on the diet. Using a least-square approximation, there was good correlation for the F A 0 subgroup (r0.99) but for the RDA subgroup there was a lower extent of correlation (r 0.72).
DISCUSSION
In PKU there is a metabolic block in the conversion of phenylalanine to tyrosine. The absorbed phenylalanine is used for protein synthesis and excess phenylalanine will accumulate in the body fluids and the disorder, if untreated, leads to permanent brain damage. The therapy is to give just as much phenylalanine as is required for protein synthesis, the phenylalanine intake being regulated by the plasma phenylalanine level. To cover the requirement for protein, a protein hydrolysate devoid of phenylalanine is given. Median values for the two groups were significantly different: *P < 0.05, **P < 0.01, ***P < 0.005. RDA, group receiving protein at a level based on the recommendations of (US) Food and Nutrition Board (1974, 1980) ; FAO, group receiving protein at the levels of intake corresponding to the Joint FAO/WHO ad hoc. Expert Committee (1973) safe levels. In the present study one group of children was given a protein intake based on the Recommended Daily Allowances of the (US) Food and Nutrition Board (1974, 1980) , and that of the other group of children followed the recommendations of the Joint FAO/WHO ad hoc Expert Committee (1973). For both groups the protein was derived from a protein hydrolysate, milk, vegetables and fruit. The phenylalanine intake necessary to maintain the plasma phenylalanine at the required concentration was greater in the RDA group than in the F A 0 group. In the RDA group the intakes during the first and second year of life were 39 and 26 mg/kg per d respectively. In the F A 0 group the corresponding intakes were 34 and 23 mg/kg per d. The broader range of phenylalanine intake in the RDA group compared with the F A 0 group was probably caused by the corresponding broader range of protein intake. During the first 4 months of age the difference was not statistically significant, probably because some of the F A 0 children actually received more protein than the RDA children. From 5 to 15 months of age the difference was statistically significant and the weight gain was the same in both groups during this period.
A more detailed examination of phenylalanine intake in the first months of life in relation to protein intake was made by comparing infants weighing approximately the same at the start of dietary treatment. In these subgroups there was no overlap in protein intake between the two groups either in terms of protein hydrolysate alone or as protein hydrolysate and milk protein. The period of 76 d was chosen because during this period the only intact protein given to all the infants was cow's milk protein. More phenylanine was required in &he RDA subgroup than in the F A 0 subgroup and Fig. 1 shows that with the same weight gain more phenylalanine was required in the RDA subgroup than in the F A 0 subgroup. Fig. 1 also shows that within each subgroup there was a correlation between weight gain and phenylalanine intake. The correlation was very good for the F A 0 subgroup but not as good for the RDA subgroup, probably because the F A 0 subgroup had been followed more closely, with more frequent and smaller increases in protein hydrolysate.
We believe that the greater phenylalanine intake in the RDA group compared with the F A 0 group reflects a greater N retention in the former group. This increased retention cannot be explained by a greater weight gain in the RDA group as the mean weight gain at 5 and 15 months of age was the same for the two groups. There are, however, possible alternative explanations. The higher intake of phenylalanine in the RDA group could be accounted for by more phenylalanine hydroxylase (phenylalanine 4-monooxygenase; EC 1 .14.16.1) activity remaining in the RDA children compared with the FA0 children. However, it seems unlikely that all such children should be in the RDA group.
Phenylalanine is also lost in the urine and faeces. The difference in phenylalanine intake cannot be accounted for by a difference in phenylalanine excretion in the urine, since the loss of phenylalanine in the urine is very small and is influenced only by the plasma level of phenylalanine which had been equally-well regulated in both groups (except for child no. 5 in the RDA subgroup who had high plasma phenylalanine values throughout the first 76 d with dietary treatment).
Phenylalanine in the morning urine of fasted subjects has been analysed in ten normal children from 3 to 5 years of age, ten samples from the RDA children from 2.8 to 5.8 years of age and in seven samples from the F A 0 children from 0-9 to 3-8 years of age. The values @mol/l; median and range) were 0.08 (0.04-0.14), 0.31 (0-061.02) and 0.31 (0.07-1.16) respectively. Faeces N is derived from two sources, one being the N in the diet. In the present study the difference in N was almost exclusively the N derived from Albumaid XP which contains no phenylalanine and only a small amount of milk protein. Thus the difference in phenylalanine intake could not be explained by faecal losses. The other source of N in faeces is endogenous N. This N represents N from intact protein containing phenylalanine. At least for rats the amount of endogenous N in faeces is dependent on the amount of food eaten and not on the percentage of protein in the diet. This N has been estimated to be 20mg/kg per d for infants (Joint FAO/WHO, 1973) . It thus seems unlikely that the difference in phenylalanine intake could be accounted for by a difference in this endogenous N, particularly as faeces N losses are small when only amino acids are given. A similar conclusion was reported by Snyderman et al. (1964) who gave infants amino acids equivalent to 3 g protein/kg per d. Mean faecal N losses were 32 mg/kg per d.
The retention of N, or rather body composition, is influenced by the N content of the diet during infancy and until chemical maturation is accomplished. Our results indicate that only a small increase in protein intake of about 0.6 g/kg per d is enough to increase the retention of N. A very rough estimate of the difference in retained N can be made from 5 to 15 months of age. If the difference in phenylalanine intake during this period were 4.2 mg/kg per d, and the mean weight were 9.0 kg, then 4.2 x 9.0 x 330 = 12472 mg more phenylalanine was retained in the RDA children than in the F A 0 children. Assuming 5% of the protein was phenylalanine, this represents 39-8 g more N retained or 0.44% higher concentration of N in the body in the RDA group than in the F A 0 group. The results of our earlier study suggested that the F A 0 group had received a marginal protein intake, and the results of the present study suggest that a protein intake slightly higher than the Joint FAO/WHO (1973) safe level is desirable. However, the present study is based on few children and several assumptions, and the results need to be confirmed by other studies using other criteria for an adequate dietary protein intake. 
